医学
低蛋白血症
化疗
淋巴细胞白血病
内科学
年轻人
队列
天冬酰胺酶
诱导化疗
体质指数
急性淋巴细胞白血病
儿科
白血病
作者
Sandra Jones,Roshni Patel,Mahvish Q. Rahim,Sandra K. Althouse,Sandeep Batra
出处
期刊:Journal of adolescent and young adult oncology
[Mary Ann Liebert]
日期:2022-12-01
卷期号:11 (6): 600-604
被引量:1
标识
DOI:10.1089/jayao.2021.0136
摘要
Acute venous thromboembolisms (VTEs) are serious complications that occur during acute lymphoblastic leukemia (ALL) chemotherapy. The data elucidating risk factors for developing VTEs are limited in adolescent and young adult patients being treated per pediatric ALL protocols. In a cohort of 66 patients, 14 (21%) experienced VTEs. The majority of VTEs occurred during induction chemotherapy after the first dose of asparaginase, and in the upper extremities. Five-year relapse-free and overall survival were not impacted by VTEs. Contrary to VTEs in adults, hypoalbuminemia and increased body mass index were not associated with an elevated risk of VTE.
科研通智能强力驱动
Strongly Powered by AbleSci AI